Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression [NA]

View source ↗

Summary

A clinical trial is evaluating focused ultrasound neuromodulation as a treatment for treatment-resistant depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Focused Ultrasound Neuromodulation

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Treatment-Resistant Depression, Treatment-resistant Depression (TRD) | NA | Status: RECRUITING